65U-93656-18774
3 vaccinations
7 coded responses
23 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 334 / FL
- Registered
- 2021-04-29
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
EKV-14550-77045
Child or adolescent in my care · Female · 2022-01-29
Timeline
-
2021-04-27
Dose 1 — Pfizer-BioNTech
-
2021-04-29
Registered in v-safe
- 2021-04-30
- 2021-05-01
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-11
-
2021-05-18
Dose 2 — Pfizer-BioNTech
-
2021-05-25
Survey response — day 7, dose 2MedDRA: Arthralgia, Musculoskeletal stiffness, Myalgia — Feeling: Fair · Be unable to workFree text: Joint and muscle pain and stiffness on Left shoulder and arm where shot was doneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-01
- 2021-06-08
- 2021-06-15
- 2021-06-22
- 2021-07-01
-
2021-11-16
Survey response — 6 months, dose 2MedDRA: Disturbance in attention, Hypersensitivity, Memory impairment, Pre-existing disease — Feeling: FairFree text: Noticed since my vaccine which i did not realize till now, that I had been more forgetful, i have more blank mind and difficulty concentrating. It has to take more deliberate effort from me to focus. My allergies has been back too since my vaccine.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-28
Dose 3 — Pfizer-BioNTech
-
2022-01-29
Survey response — days 1–6 daily, dose 3MedDRA: Unevaluable event — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: NoneMedDRA releases: 2024-11 · check-in free text available
-
2022-01-29
Report sent to call center — days 1–6 daily, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-01-30
-
2022-02-02
Survey response — days 1–6 daily, dose 3MedDRA: Anxiety, Aphasia, Bradyphrenia, Increased appetite, Memory impairment, Mental impairment — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: , increased appetite, Forgetting the names of some people i knee before, difficulty finding words to express thoughts, doing things or saying words without thinking, lazy mind, sleepy, anxious/anxietyMedDRA releases: 2024-11 · check-in free text available
- 2022-02-06
-
2022-02-11
Survey response — day 14, dose 3MedDRA: Dysphemia — Feeling: GoodFree text: Mild stuttering of wordsMedDRA releases: 2024-11 · check-in free text available
-
2022-02-14
Call successfulParticipant prefers to complete VAERS report online
-
2022-02-20
Survey response — day 21, dose 3MedDRA: Aphasia, Memory impairment — Feeling: FairFree text: Im still more forgetful, difficultyveith word findingMedDRA releases: 2024-11 · check-in free text available
- 2022-02-25
- 2022-03-04
-
2022-07-31
Survey response — 6 months, dose 3MedDRA: Asthenia, Bowel movement irregularity, Dyspepsia, Nausea, Sensory processing sensitivity — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Nausea, sensitivity to smell, digestive difficulty, weakness, difficulty with bowel movementMedDRA releases: 2024-11 · check-in free text available
- 2023-01-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-27 | Pfizer-BioNTech | |
| 2 | 2021-05-18 | Pfizer-BioNTech | |
| 3 | 2022-01-28 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 8 — day 7, dose 2
Systemic reaction (other): Joint and muscle pain and stiffness on Left shoulder and arm where shot was done
Release 10 — 6 months, dose 2
Symptoms: Noticed since my vaccine which i did not realize till now, that I had been more forgetful, i have more blank mind and difficulty concentrating. It has to take more deliberate effort from me to focus. My allergies has been back too since my vaccine. cut off by CDC
Release 11 — days 1–6 daily, dose 3
Healthcare visit (other): None
Systemic reaction (other): , increased appetite, Forgetting the names of some people i knee before, difficulty finding words to express thoughts, doing things or saying words without thinking, lazy mind, sleepy, anxious/anxiety
Release 11 — day 14, dose 3
Symptoms: Mild stuttering of words
Release 11 — day 21, dose 3
Symptoms: Im still more forgetful, difficultyveith word finding
Release 12 — 6 months, dose 3
Symptoms: Nausea, sensitivity to smell, digestive difficulty, weakness, difficulty with bowel movement
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Aphasia | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Bowel movement irregularity | · | · | ✓ |
| SD | Disturbance in attention | · | · | ✓ |
| SD | Dyspepsia | · | · | ✓ |
| SD | Dysphemia | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Memory impairment | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Sensory processing sensitivity | · | · | ✓ |
| SRO | Anxiety | · | · | ✓ |
| SRO | Aphasia | · | · | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Bradyphrenia | · | · | ✓ |
| SRO | Increased appetite | · | · | ✓ |
| SRO | Memory impairment | · | · | ✓ |
| SRO | Mental impairment | · | · | ✓ |
| SRO | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release